R&D INSIGHTS Featured March 4, 2026 R&D Insights The Problem with Primary Market Research March 4, 2026 R&D Insights Read more → March 4, 2026 R&D Insights February 10, 2026 R&D Insights Plan for the Best, Prepare for the Worst - Handling Uncertainty in R&D February 10, 2026 R&D Insights Read more → February 10, 2026 R&D Insights January 27, 2026 R&D Insights Finding the Best R&D Opportunities January 27, 2026 R&D Insights Read more → January 27, 2026 R&D Insights December 29, 2025 R&D Insights Measuring Risk in R&D December 29, 2025 R&D Insights Read more → December 29, 2025 R&D Insights November 11, 2025 Oncology, R&D Insights How Equinox Group Models Drugs in R&D: The Case of Alecensa in 1L ALK+ NSCLC November 11, 2025 Oncology, R&D Insights Read more → November 11, 2025 Oncology, R&D Insights October 30, 2025 Oncology, R&D Insights What indications should we focus on? October 30, 2025 Oncology, R&D Insights Read more → October 30, 2025 Oncology, R&D Insights August 26, 2020 Oncology, R&D Insights Comparing Opportunity Across Subpopulations: Rozlytrek as a Case Study August 26, 2020 Oncology, R&D Insights Read more → August 26, 2020 Oncology, R&D Insights April 2, 2020 Oncology, R&D Insights Finding the Right Price for a Drug across Multiple Indications; Learnings from Keytruda April 2, 2020 Oncology, R&D Insights Read more → April 2, 2020 Oncology, R&D Insights June 5, 2019 Oncology, R&D Insights How to Price an Oncology Drug June 5, 2019 Oncology, R&D Insights Read more → June 5, 2019 Oncology, R&D Insights
